ENDRA Life Sciences NDRA Income Statement (2016-2026)

NASDAQ NDRA
$5.41 -0.03 (-0.64%)
As of: Aug 27, 2026 · 3:24 PM EDT
Reported Financials

ENDRA Life Sciences Quarterly Income Statement

Periods 42 quarters
Latest Jun 2026

ENDRA Life Sciences reported net income of $0.16M for the quarter ended Jun 2026. This income statement covers 42 quarters of results from Mar 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
Cost of RevenueCost of Rev
Gross Profit
Operating items
Research & DevelopmentR&D
1.17M1.42M1.21M1.85M1.83M1.66M1.39M1.40M1.63M0.58M1.04M0.72M0.79M0.64M0.53M0.38M0.43M0.51M0.78M0.23M
Selling, General & AdministrativeSG&A
1.20M1.27M1.30M1.38M1.17M1.32M1.37M1.35M1.25M0.73M1.50M1.35M0.63M3.57M0.87M0.85M0.89M1.11M1.39M1.24M
Other Operating ExpensesOther Opex
0.28M0.38M0.34M0.34M0.42M0.33M0.18M0.25M0.24M0.15M0.24M0.16M0.08M0.09M0.07M0.07M0.05M0.01M0.00M0.01M
Operating ExpensesOpex
2.65M3.07M2.86M3.57M3.42M3.31M2.94M2.99M3.13M1.46M2.78M2.23M1.51M4.30M1.47M1.30M1.37M1.62M2.17M1.48M
Operating IncomeOp. Inc
-2.65M-3.07M-2.86M-3.57M-3.42M-3.31M-2.94M-2.99M-3.13M-1.46M-2.78M-2.23M-1.51M-4.30M-1.47M-1.30M-1.37M-1.62M-2.17M-1.48M
EBIT
-2.65M-3.07M-2.86M-3.57M-3.42M-3.31M-2.94M-2.99M-3.13M-1.46M-2.78M-2.23M-1.51M-4.30M-1.47M-1.30M-1.37M-1.62M-2.17M-1.48M
Non-operating items
Non Operating Interest Expenses
0.00M0.00M0.00M
Non Operating Investment IncomeNon-Op. Investment Inc.
0.74M1.29M
Other Non Operating IncomeOther Non Op Inc.
-0.01M-0.30M-0.00M-0.02M-0.02M0.02M0.00M0.44M-0.03M0.92M0.00M0.00M3.07M0.01M0.43M0.08M0.04M-0.10M
Non Operating IncomeNon Op. Inc.
-0.01M-0.03M-0.00M-0.02M-0.02M0.02M-0.00M0.44M0.03M-0.00M0.00M-0.85M0.15M0.43M0.08M-0.23M-1.55M0.86M1.64M
Net income details
EBT
-2.66M-3.10M-2.86M-3.59M-3.44M-3.29M-2.94M-2.56M-3.10M-1.46M-2.78M-2.23M-2.35M-4.15M-1.04M-1.23M-1.60M-3.17M-1.31M0.16M
Tax ProvisionsTaxes
-2.42M
Profit After TaxPAT
-2.66M-3.10M-2.86M-3.59M-3.44M-3.29M-2.94M-2.56M-3.10M-1.46M-2.78M-2.23M-2.35M-4.15M-1.04M-1.23M-1.60M-3.17M-1.31M0.16M
Income from Continuing OperationsIncome (Continuing)
-2.66M-3.10M-2.86M-3.59M-3.44M-3.29M-2.94M-2.56M-3.10M-1.46M-2.78M-2.23M-2.35M-1.73M-1.04M-1.23M-1.60M-3.17M-1.31M0.16M
Consolidated Net IncomeConsol Net Inc.
-2.66M-3.10M-2.86M-3.59M-3.44M-3.29M-2.94M-2.56M-3.10M-1.46M-2.78M-2.23M-2.35M-1.73M-1.04M-1.23M-1.60M-3.17M-1.31M0.16M
Income towards Parent CompanyParent Net Inc
-2.66M-3.10M-2.86M-3.59M-3.44M-3.29M-2.94M-2.56M-3.10M-1.46M-2.78M-2.23M-2.35M-1.73M-1.04M-1.23M-1.60M-3.17M-1.31M0.16M
Preferred Dividend PaymentsPref Dividends
0.01M
Net Income towards Common StockholdersNet Income
-2.66M-3.10M-2.86M-3.59M-3.44M-3.29M-2.94M-2.56M-3.10M-1.46M-2.78M-2.23M-2.35M-1.73M-1.04M-1.23M-1.60M-3.17M-1.31M0.16M
Additional items
EPS (Basic)
-1.27-1.52-1.33-1.17-1.09-1.14-0.93-0.43-0.40-0.23-0.26-0.08-9.54-8.57-1.86-1.71-2.10-4.03-1.090.12
EPS (Diluted)
-401.41-763.39-613.08-9.54-8.57-1.86-1.71-2.10-4.03-1.090.06
Shares Outstanding
2.10M2.05M2.15M3.08M3.16M2.89M3.17M6.00M7.68M6.36M10.80M27.28M0.25M0.20M0.56M0.72M0.76M0.79M1.20M1.32M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.00M0.00M0.00M0.25M0.20M0.56M0.72M0.76M0.79M1.20M2.48M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
2.11M2.13M2.15M3.16M3.16M3.17M3.17M6.00M8.41M6.36M10.91M27.28M0.25M0.20M0.56M0.75M0.79M0.79M1.24M1.50M
EBITDA
-2.65M-3.07M-2.86M-3.57M-3.42M-3.31M-2.94M-2.99M-3.13M-1.46M-2.78M-2.23M-1.51M-4.30M-1.47M-1.30M-1.37M-1.62M-2.17M-1.48M
Interest ExpensesInt Expense
0.00M0.00M0.00M
Tax Rate
58.25%